Novartis stocks drug cabinet with "Big-3" arthritis blockbusters
July 14, 2017 at 07:44 AM EDT
ZURICH, July 14 (Reuters) - Switzerland's Novartis is stocking up cheaper versions of the world's top-selling arthritis medicines, hoping a broad portfolio gives it an edge on rivals with narrower offerings.
